Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Vetanco Vetanco registered products in Russia, Turkey and Azerbaijan - Vetanco

Vetanco Vetanco's presence at the Latin American Scientific Conference

Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept

Vetanco Vetanco registered products in Russia, Turkey and Azerbaijan - Vetanco

Vetanco Sherry Layton, closing keynote at the 3rd edition of the Animal Microbiome Congress Europe - Vetanco

Sherry Layton - Chief Executive Officer - Vetanco USA

Emerging Diseases 2021, Emerging Infectious Diseases Conferences in 2021, Infectious Disease Conferences 2021, Emerging Infectious Diseases Conferences 2021, Rare Diseases 2021 Conferences, Europe, USA

Sherry Layton - Chief Executive Officer - Vetanco USA

Sherry Layton - Chief Executive Officer - Vetanco USA

Vaccines Conference-2022, Global Conference on Vaccines Research and Development